Paul Tudor Jones Pfizer Inc Call Options Transaction History

Tudor Investment Corp Et Al

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $2.93 Million - $3.37 Million	-113,300 Reduced 14.04%	693,600 $19.2 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $7.76 Million - $10.1 Million	296,800 Added 58.18%	806,900 $23.2 Million
Q3 2023 Nov 15, 2023	BUY	$32.09 - $37.51 $7.53 Million - $8.8 Million	234,500 Added 85.09%	510,100 $16.9 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $8.53 Million - $9.87 Million	236,100 Added 597.72%	275,600 $10.1 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $1.56 Million - $2.03 Million	39,500 New	39,500 $1.61 Million

Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $5.83 Million - $8.64 Million	-141,100 Reduced 95.99%	5,900 $348,000
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $5.77 Million - $7.41 Million	147,000 New	147,000 $6.32 Million

3,159

3.68B

67.4M

113M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.